BioArmix

BioArmix Overview

BioArmix develops biological solutions to combat bacterial plant pathogens, promoting sustainable agriculture and enhanced food security. The company uses naturally occurring, non-GMO predatory bacteria that target harmful gram-negative bacterial pathogens affecting crops. To ensure practicality and effectiveness, BioArmix employs a proprietary encapsulation technique, preserving the viability of the bacteria in a dry powder form that remains stable at room temperature.

Latest News

Oct 24, 2024 · agfundernews.com

growth-positive

Predator too? BioArmix tackles bacterial pathogens with novel ‘predatory’ biologicals

BioArmix, an Israeli startup founded in 2023, is pioneering the use of naturally occurring, non-GMO predatory bacteria to combat gram-negative bacterial pathogens in agriculture. This innovative approach, which has been explored in human medicine, is now being tested in large-scale field trials in Israel. The company aims to provide a sustainable solution to bacterial pathogens affecting crops like potatoes and apples, as traditional methods face regulatory challenges. BioArmix is seeking strategic partners and investment to scale up its operations, with interest from investors due to the limited existing solutions for bacterial pathogens in agriculture. The company is affiliated with YDLabs Israel and supported by the Israeli Innovation Authority.

InvestmentPartners

Funding

Team Members

5

Employees: 1-10

Web & Social Links

Locations

HaMerkava St 4, Nof HaGalil, Israel

Photos & Videos

No files yet

BioArmix Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info